leukemia
EC Approves Amgen's Blincyto as Consolidation Treatment for Certain Newly Diagnosed Leukemia Cases
The EC's decision was based on results from a Phase III trial of Blincyto with multiphase consolidation chemotherapy.
NeoGenomics, Adaptive Biotech Partner to Offer Combined Blood Cancer Testing
Doctors ordering NeoGenomics Compass test packages will have the option of including Adaptive's ClonoSeq minimal residual disease assay.
BeiGene, CLL Society Partner to Promote Biomarker Testing in CLL, SLL
The partnership will support a campaign intended to increase the use of genomic testing to guide personalized therapy and improve outcomes.
Aptose Partners With NCI to Study Tuspetinib in MyeloMATCH Trials
NCI will include the multi-kinase inhibitor in the umbrella trial evaluating targeted therapy combinations in AML and MDS patients.
Senti Biosciences Announces $37.6M PIPE Financing, Reports Early Data From Phase I CAR-NK Trial
The firm plans to put the proceeds toward further developing its cell therapy in CD33- or FLT3-expressing AML and for other R&D activities.
Jul 18, 2024